Multiple Manufacturers



Multiple Manufacturers

Treanda HCPCS:


HCPCS Code Descriptor:

Injection, bendamustine hcl (treanda), 1 mg


J Code

Treanda NDCs:

63459-0391-20, 60505-6096-00, 71288-0103-20, 68001-0572-41, 16729-0251-05, 63459-0390-08, 55150-0392-01, 16729-0250-03, 60505-6095-00, 71288-0102-10, 68001-0571-41, 55150-0391-01

Primary Type:


Generic/Specialty Status:


Route of Administration:


Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Treanda:

TREANDA is an Oncology drug manufactured by Cephalon and administered via the Intravenous route of administration. The J Code: J9033 is aligned to the drug TREANDA.

TREANDA is an alkylating drug commonly used to treat non-Hodgkins lymphoma that has not improved with rituximab treatment and chronic lymphocytic leukemia. It’s a mechlorethamine derivative that forms alkyl groups that covalently bond with electron-rich nucleophilic structures like DNA, causing DNA crosslinks that can lead to cell death via various pathways. TREANDA (J9033) is commonly used for treatment in adult populations. It is contraindicated for pregnant women and patients with renal or hepatic insufficiency.


J9033 Added Date:

January 1, 2009

J9033 Effective Date:

January 1, 2017

J9033 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Treanda billing and coding information.
Our team did not identify a source for Treanda patient assistance information. Please reach out to our team if you feel that this is a mistake.
TREANDA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for TREANDA. Please check back in a few weeks.